SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group (NBIS) is trending after announcing a significant multi-billion dollar AI infrastructure agreement with Microsoft, driving excitement about the company's growth potential. Community discussions revolve around the deal's implications for revenue and future partnerships, with some speculating on a potential rise to become a major player in the AI cloud sector. Some investors believe this is just the beginning, while others are concerned about a potential offering given the capital expenditure.

Eightco Holdings, Inc. is a publicly traded holding company, which operates in the consumer products and e-commerce markets, focusing on developing and deploying innovative technology, and capital solutions to empower small to medium-sized businesses. It operates through the North America and Europe geographical segments. The company was founded in 1966 and is headquartered in Easton, PA.

Eightco Holdings Inc

Eightco Holdings ($OCTO) is trending due to news regarding Pineapple Financial ($PAPL) launching a digital asset treasury strategy anchored in INJ, which some traders believe could be a model for OCTO. The community is actively discussing the potential for a short squeeze and comparing it to other high-flying stocks, while also debating the sustainability of the price surge following a large private placement. There are discussions about related cryptocurrency plays and possible upcoming news catalysts.

Wolfspeed, Inc. is an innovator of wide bandgap semiconductors, focused on silicon carbide and gallium nitride (GaN) materials and devices for power and radiofrequency (RF) applications. Its product families include silicon carbide and GaN materials, power devices and RF devices, and its products are targeted for various applications such as electric vehicles, fast charging, 5G, renewable energy and storage, and aerospace and defense. The company was founded by Calvin H. Carter Jr., John W. Palmour, F. Neal Hunter, Eric Hunter, and John Edmond in 1987 and is headquartered in Durham, NC.

Wolfspeed Inc

Wolfspeed ($WOLF) is trending as investors discuss the company's restructuring plan and potential outcomes for shareholders, including possible dilution. Community members are weighing the potential for a short squeeze against concerns about the value of their holdings post-reorganization. Chatter revolves around the potential for government intervention and the impact of upcoming earnings.

Shiba Inu (SHIB) is a meme token which began as a fun currency and has now transformed into a decentralized ecosystem. During the initial launch, 50% of the supply was allocated into Vitalik Buterin's ethereum wallet.   As a result of that, Vitalik proceeded to donate 10% of his SHIB holdings to a COVID-19 relief effort in India and the remaining 40% is burnt forever. That donation was worth about $1 billion at that time, which makes it one of the largest donation ever in the world.  What is the Shiba Inu community working on right now? The Shiba Inu team launched a decentralized exchange called Shibaswap with 2 new tokens, LEASH and BONE. LEASH is a scarce supply token that is used to offer incentives on Shibaswap. BONE is the governance token for holders to vote on proposals on Doggy DAO.

Shiba Inu

Shiba Inu is trending amidst community discussions about potential rallies and burn rates, with some speculating about future price movements and potential returns. The conversation also includes comparisons to other meme coins and mentions of broader market factors that could influence its performance. Despite the optimism, some users express concerns about the project's long-term viability.

Cleancore Solutions, Inc. engages in the development and production of cleaning products that produce pure aqueous ozone for professional, industrial, or home use. Its products include fill station 1.0. fill station 3.0, power caddy, minicaddy, ice treatment machine, O3 cleanpak, commercial laundry, and residential laundry. The company was founded on August 23, 2022 and is headquartered in Omaha, NE.

CleanCore Solutions Inc. - Ordinary Shares - Class B

Cleancore Solutions Inc.

Cleancore Solutions is trending as community members discuss its recent acquisition of a significant amount of Dogecoin, sparking speculation about a potential surge similar to $OCTO; the company's new Dogecoin treasury is generating excitement. Bullish sentiment is fueled by the company's fundamentals, including revenue and earnings, with some traders suggesting institutions may be accumulating positions.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is trending as investors digest the implications of a revised corporate presentation emphasizing MASH/AUD/ALD while seemingly deprioritizing the obesity program. The community is actively debating the strategic shift, potential lawsuits related to the obesity program, and the departure of the CTO. Some are optimistic about the focus on liver diseases and potential for partnerships, while others express concern about the company's financial position and competitive landscape.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

APLD is trending amid speculation and excitement surrounding potential deals with major hyperscalers, particularly after competitor NBIS announced a significant agreement with Microsoft. The community is buzzing with rumors of upcoming contracts and anticipating a short squeeze, further fueled by the launch of a leveraged ETF tracking APLD. Discussions also involve the broader AI infrastructure boom and APLD's position within the data center sector.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

Iris Energy Ltd

Iris Energy is trending as chatter revolves around its potential in the AI data center space following a competitor's recent deal with Microsoft, with some speculating IREN could be next. The community is also discussing the company's financials, partnership with NVIDIA, and potential price targets, expressing overall bullish sentiment. Some are noting its Bitcoin mining operations in addition to AI.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending due to the unveiling of their solid-state batteries in a Ducati motorcycle, showcased at IAA Mobility, generating excitement about potential commercialization. The community is buzzing about the implications of this demonstration, particularly its potential for faster charging and higher energy density in EVs. Some investors believe the partnership with VW and the move beyond the lab validates the long-term investment case, while others remain skeptical about timelines and profitability.

Lion Group Holding Ltd. operates an all-in-one, state-of-the-art trading platform that offers a wide spectrum of products and services. It operates through the following segments: Futures and Securities Brokerage Services, Contract-For-Difference (CFD) Trading, Total Return Service (TRS) Trading and OTC Stock Option Trading. The company was founded by Jian Wang in 2015 and is headquartered in Singapore.

Lion Group Holding Ltd - ADR

Lion Group Holding Ltd

Lion Group (LGHL) is trending as traders draw comparisons to past runners like $OCTO and $SNTG, focusing on its low float and potential for a significant squeeze. Community members are actively discussing its crypto treasury strategy and eyeing potential overnight gains, with some suggesting it could reach $5 or even $10. The stock's volatility and potential for high returns, coupled with crypto-related news, are key drivers behind the current interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Savara Announces New Employment Inducement Grant

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to five new employees. On February 12...

Savara Announces Manuscript on Long-Term Outcomes With Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Published in ERJ Open Research

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced a manuscript titled, Long-Term Outcomes in Five Patients...

Savara Announces Participation in Upcoming Healthcare Investor Conferences

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that members of its management team will be attending two...

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to five new employees. On December 20...

Savara Initiates Rolling Submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI* for the Potential Treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, initiated a rolling submission of a BLA to the FDA for MOLBREEVI for the...

Savara Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that the Company will present and host 1x1 meetings at the...

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to four new employees. On November 20...

Savara Announces Encore Presentation of Results from the Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the British Thoracic Society Winter Meeting 2024

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that an encore presentation of results from the pivotal...

Savara Announces Participation in Upcoming Healthcare Conferences

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that members of its management team will be attending the...

Savara Reports Third Quarter 2024 Financial Results and Provides Business Update

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the third quarter ending September 30, 2024...

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is headquartered in Langhorne, PA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$0.13	--	--	N/A
Q2 '25	-$0.12	-$0.14	-16.67%	MISSED
Q1 '25	-$0.13	-$0.12	4.55%	BEAT
Q4 '24	-$0.11	-$0.13	-14.04%	MISSED
Q3 '24	-$0.11	-$0.11	-1.32%	MISSED

SVRA
Savara Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q2 '25

Historical Earnings

Latest SVRA News

SVRA Savara Inc